ETON
Eton Pharmaceuticals, Inc.
Eton Pharmaceuticals, Inc. (ETON) has 5 SEC Form 4 filings (12 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 16, 2026.
The most active filer is 10% Owner Opaleye Management Inc. with 4 filings. Insiders have net sold $7.5M over the trailing 6 months.
- Industry:Drug Manufacturers - Specialty & Generic
- CEO:Sean E. Brynjelsen
- Employees:44
- HQ:Deer Park, IL, US
- IPO:2018-11-14
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$7.5M
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$1.0B
latest known value
Related companies
Eton Pharmaceuticals, Inc. is in the Healthcare sector.